Navigation Links
Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Date:8/28/2007

SEATTLE, Aug. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) today announced that it had received a Deficiency Letter (the "Letter") from Nasdaq indicating that the Company's recently completed registered offering of Series C 3% Convertible Preferred Stock (the "Series C Preferred") and warrants did not comply with voting rights requirements set forth in Nasdaq Marketplace Rule 4351 and IM 4351. The Nasdaq staff verbally notified the Company of such noncompliance on August 9, 2007 and, in response to this verbal notification, the Company took action to cure the deficiency by amending the Articles of Amendment of the Company's Articles of Incorporation, which set forth the rights and preferences of the holders of the Series C Preferred (the "Articles of Amendment"). The amendment to the Articles of Amendment (the "Amendment") adjusted the conversion ratio of the Series C Preferred for purposes of the voting rights provision of the Articles of Amendment, and had the effect of reducing the number of votes that the holders of the Series C Preferred have because it increased the conversion price from $3.90 to $4.53 for purposes of the voting rights provision. The Amendment did not change the conversion price in any other provision of the Articles of Amendment, including but not limited to the provision on conversion of such Series C Preferred into shares of common stock.

The letter confirms that, subject to the public announcement requirements of Nasdaq Marketplace Rule 4803(a), the Company has regained compliance with Nasdaq Marketplace Rule 4351 and IM 4351 and the matter is now closed.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Milwaukee takes another step in electronic patient data exchange
3. Ethics Board site offers welcome contrast to state IT mistakes
4. It takes more than money to reach the top
5. CATI takes tech transfer model national
6. Green economic plan takes cue from Indiana
7. Local software company takes Google to court over a patent
8. American Family CIO takes entrepreneurial approach to innovation
9. TDS takes top spot in region in customer satisfaction rankings
10. Innovative health care takes more than just IT automation
11. Centralization mania takes over
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Cystic fibrosis (CF) is a genetic ... gastrointestinal organs. In particular, very thick mucus accumulates in ... difficult to clear, occludes the airways, and creates an ... frequently suffer from chronic biofilm infections, and ultimately succumb ... approach to treating the major challenges in the lungs ...
(Date:10/2/2014)... Mich. (PRWEB) October 02, 2014 MS ... with Hile Creative to refine its marketing approach. Backed ... MS Bioworks serves researchers in the biological sciences, including ... Bioworks has already seen substantial growth over the past ... with current customers, the company plans to launch a ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 At a time ... Bel-Art Products has introduced a new kind of squeeze ... market is the Scienceware® Squeeze Rite™ Wash Bottle , ... tube position within the bottle reduces the waste of reagents, ... of those liquids. , “Easier to squeeze when compared to ...
(Date:10/2/2014)... CARLOS, Calif. and BRIDGEWATER, ... Corporation (NYSE: XON) , a leader in synthetic ... seventh largest generic drug manufacturer by volume in ... second Exclusive Channel Collaboration (ECC) for a target ... expression system, the goal of the collaboration is ...
Breaking Biology Technology:Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Wis . - The Medical College of Wisconsin ... National Institute of Neurological Disorders and Stroke ... , ,The research, which will be led by principal ... examine the link between oxygen deficit and loss of ...
... Green Bay, Wis. - For six years, Steve Matheys served ... experience during that period - 1998 to 2004 - convinced him ... for bigger and better things in the executive suite. , ,Provided ... is. , ,Matheys, who now serves as executive vice president of ...
... Milwaukee, Wis . - He is fast becoming one of ... and if he has his way chief information officers and ... when they move to fill IT staff openings. , ... during the Wisconsin Entrepreneur's Conference in Milwaukee, is ...
Cached Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... dinner fat intake seem to influence negatively the sleep pattern ... be presented on Tuesday at SLEEP 2008, the 22nd Annual ... study, authored by Cibele Crispim, of the Federal University of ... 20-45 years of age, whose food intake was analyzed by ...
... forensic scientists at the University of Copenhagen has studied human ... to the iron age, and discovered a man who appears ... beings were as genetically diverse 2000 years ago as they ... than was previously thought. The findings also suggest that people ...
... A new book, Grounds for Knowledge , ... modern buildings and the striking landscape that surrounds them. ... L. Watson, who, together with her husband James D. Watson ... picturesque grounds of CSHL for almost four decades. The ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: